If you need more lookups,
subscriptions start at $34 USD/month.
Edward Painter Location
New York, NY, US
Edward Painter Work
Founder, Chairman and COO @ A2A Pharmaceuticals Inc. (July 2019 - Present)
Managing Member @ SHomer Capital LLC (November 2011 - Present)
Founder and Chief Executive Officer @ (March 2016 - July 2019)
Business Development Executive @ Startup Pharmaceutical Company (June 2015 - February 2016)
Senior Vice President @ (January 1998 - May 2015)
Senior Vice President @ Oppenheimer & Co. (January 1995 - January 1998)
Vice President @ (July 1992 - July 1995)
Vice President @ (July 1990 - July 1992)
Analyst @ (January 1987 - January 1990)
Analyst @ Salomon Brothers (January 1984 - January 1987)
Edward Painter Education
University of Illinois at Urbana-Champaign - College of Business
MBA (Finance)
1983-1985
Illinois Wesleyan University
BA (Business)
1980-1984
Edward Painter Skills
Financial Services
Investor Relations
Asset Allocation
Venture Capital
Management
Due Diligence
Mergers & Acquisitions
Emerging Markets
Finance
Strategy
Start-ups
Investment Management
Mutual Funds
Business Strategy
Business Development
Equities
Strategic Planning
Leadership
Public Speaking
Mergers and Acquisitions
Microsoft Office
Public Relations
Start Ups
Wealth Management
Private Banking
Project Management
Financial Analysis
Marketing Communications
SQL
Analysis
Edward Painter Summary
Edward Painter, based in New York, NY, US, is currently a Founder, Chairman and COO at A2A Pharmaceuticals Inc.. Edward Painter brings experience from previous roles at SHomer Capital LLC, A2A Pharmaceuticals, Startup Pharmaceutical Company and UBS Investment Bank. Edward Painter holds a 1983 - 1985 MBA in Finance @ University of Illinois at Urbana-Champaign - College of Business. With a robust skill set that includes Financial Services, Investor Relations, Asset Allocation, Venture Capital, Management and more. Edward Painter has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Edward Painter?
Find contact details for 700 million professionals.